Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2005-11-21
pubmed:abstractText
This study examined a pretarget radioimmunotherapy strategy for treatment of an i.p. tumor model (LS174T).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/B72.3 antibody, http://linkedlifedata.com/resource/pubmed/chemical/Biotin, http://linkedlifedata.com/resource/pubmed/chemical/DOTA-biotin, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Indium Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/Lutetium, http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/Streptavidin, http://linkedlifedata.com/resource/pubmed/chemical/Yttrium Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/tumor-associated antigen 72
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8180-5
pubmed:meshHeading
pubmed-meshheading:16299250-Animals, pubmed-meshheading:16299250-Antibodies, Monoclonal, pubmed-meshheading:16299250-Antibodies, Neoplasm, pubmed-meshheading:16299250-Antigens, Neoplasm, pubmed-meshheading:16299250-Biotin, pubmed-meshheading:16299250-Cell Line, Tumor, pubmed-meshheading:16299250-Colonic Neoplasms, pubmed-meshheading:16299250-Glycoproteins, pubmed-meshheading:16299250-Humans, pubmed-meshheading:16299250-Indium Radioisotopes, pubmed-meshheading:16299250-Injections, Intraperitoneal, pubmed-meshheading:16299250-Iodine Radioisotopes, pubmed-meshheading:16299250-Lutetium, pubmed-meshheading:16299250-Mice, pubmed-meshheading:16299250-Mice, Nude, pubmed-meshheading:16299250-Organometallic Compounds, pubmed-meshheading:16299250-Radioimmunotherapy, pubmed-meshheading:16299250-Radioisotopes, pubmed-meshheading:16299250-Streptavidin, pubmed-meshheading:16299250-Survival Analysis, pubmed-meshheading:16299250-Time Factors, pubmed-meshheading:16299250-Tissue Distribution, pubmed-meshheading:16299250-Treatment Outcome, pubmed-meshheading:16299250-Xenograft Model Antitumor Assays, pubmed-meshheading:16299250-Yttrium Radioisotopes
pubmed:year
2005
pubmed:articleTitle
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
pubmed:affiliation
Department of Radiation Oncology, University of Alabama at Birmingham, Alabama 35294-6832, USA. djb@uab.edu
pubmed:publicationType
Journal Article